Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schrader, H.
Right arrow Articles by Skomedal, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schrader, H.
Right arrow Articles by Skomedal, G. N.
NEUROLOGY 1980;30:105
© 1980 American Academy of Neurology

Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin

Harald Schrader, M.D., Ole B. Gotlibsen, Tech. EEG. and Gunstein N. Skomedal, M. D.

Department of Neurology, Rikshospitalet, Oslo University Hospitals, Oslo (Dr. Schrader), and the National Centre for Epilepsy, Sandvika, Norway Mr. Gotlibsen).

Symptoms of narcolepsy/cataplexy developed in a monozygotic twin at the age of 56 years, 25 years after the onset of multiple sclerosis. The diagnosis of narcolepsy/cataplexy was confirmed by polygraphic recordings demonstrating sleep-onset periods of rapid eye movements (REM), increase in REM time per 24 hours, and disturbed nocturnal sleep. Frequent cataplectic attacks were almost completely controlled by clomipramine. These symptoms may constitute one of the paroxysmal syndromes in multiple sclerosis. The discordancy for multiple sclerosis is attributed to a submaximal risk factor in the HLA system and a strong environmental factor in only one of the twins.

Address reprint requests to Dr. Schrader, Department of Neurology, Rikshospitalet, Oslo University Hospitals, Oslo, Norway.

Accepted for publication May 25, 1979.




This article has been cited by other articles:


Home page
Mult SclerHome page
S Knudsen, P. Jennum, K Korsholm, S. Sheikh, S Gammeltoft, and J. Frederiksen
Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis
Multiple Sclerosis, July 1, 2008; 14(6): 734 - 738.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. F. Gledhill, P. R. Bartel, Y. Yoshida, S. Nishino, and T. E. Scammell
Narcolepsy Caused by Acute Disseminated Encephalomyelitis
Arch Neurol, May 1, 2004; 61(5): 758 - 760.
[Abstract] [Full Text] [PDF]


Home page
AutismHome page
B. I. Cohen
Possible Connection between Autism, Narcolepsy and Multiple Sclerosis
Autism, December 1, 1998; 2(4): 425 - 427.



Home page
Arch NeurolHome page
R. E. Kramer, D. S. Dinner, W. E. Braun, A. A. Zachary, and G. A. Teresi
HLA-DR2 and Narcolepsy
Arch Neurol, August 1, 1987; 44(8): 853 - 855.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.